OA12.05 Vemurafenib in Patients Harboring V600 and Non V600 BRAF Mutations: Final Results of the NSCLC Cohort From the AcSé Trial.

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.302
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P3.03-01 BRAF V600 and Non-V600 Mutations in Chinese Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Survival According to BRAF-V600 Tumor Mutations – An Analysis of 437 Patients With Primary Melanoma

PLoS ONE
Multidisciplinary
2014English

Biomarker Analysis of On-Treatment and at Progression Biopsies From BRIM7 - A Phase 1B Trial of Combined Vemurafenib and Cobimetinib Treatment in BRAF V600 Mutated Melanoma

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2014English

A Multi-Center Phase II Study of High Dose Interleukin-2 Sequenced With Vemurafenib in Patients With BRAF-V600 Mutation Positive Metastatic Melanoma

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2018English

BRAF -V600 Mutational Status Affects Recurrence Patterns of Melanoma Brain Metastasis

International Journal of Cancer
Cancer ResearchOncology
2017English

Targeted Treatment of Papillary Craniopharyngiomas Harboring BRAF V600E Mutations

Cancer
Cancer ResearchOncology
2019English

Reconsidering the Turnaround Times for BRAF V600 Mutation Analysis in Non-Small-Cell Lung Cancer: A Molecular Diagnosis in One Day Is Achievable for Rapid Treatment Choices

Current Oncology
Oncology
2019English

Targeted Therapy for Patients With BRAF-Mutant Lung Cancer Results From the European EURAF Cohort

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2015English

P3.01-68 Early SBRT to the Primary Tumor May Overcome the Icotinib Resistance in Patients With Advanced NSCLC Harboring EGFR Mutations

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy